DARRYL MILES: Open Payments
NPI 1669156246 · HAMMOND, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$208 in 12 payments from 7 companies in 2025. Trend: 2023 $109 · 2024 $21 · 2025 $208
Food & beverage: $208
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $71 |
| Lilly USA, LLC | 3 | $46 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| IBSA Pharma Inc. | 1 | $20 |
| HARMONY BIOSCIENCES LLC | 1 | $18 |
| EVOKE PHARMA, INC. | 1 | $17 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $17 |
Products named: MOUNJARO, CREON, Tirosint, QULIPTA, WAKIX, GIMOTI, VRAYLAR, XIFAXAN.
Industry payments across LA — which companies pay providers there.
